Community Research and Development Information Service - CORDIS

Abstract

COST Action B1 is entitled: Criteria for the choice and definition of healthy volunteers and/or patients for phase I and phase II studies in drug development. In 1995 the Action was approved for a third and final round, to run from 1995-1998, with the sub-title: Predicting and managing variability in the kinetics and effects of drugs during research, development and use. This report reviews the progress and accomplishments of the Action, the specific contributions to the field of research covered, the wider implications of the work for those involved in the development and use of drugs and the possible indirect effects on regulatory agencies, funding bodies and others.

Additional information

Authors: BOOBIS A R (EDITOR), Imperial College School of Medicine, Department of Clinical Pharmacology, London (GB)
Bibliographic Reference: EUR 18394 EN (1998) 75pp., ECU 10.00
Availability: Available from the (2)
ISBN: ISBN 92-827-4033-1
Record Number: 199811369 / Last updated on: 1998-11-10
Category: PUBLICATION
Original language: en
Available languages: en